. 2022 Aug 16;5(3):372–387. doi: 10.3138/canlivj-2021-0038

Table 3:

Liver stiffness measurements by transient elastography

	All patients (N = 569)	Previously on UDCA (n = 16)	Currently on UDCA (n = 515)	Never on UDCA (n = 38)
Liver stiffness, kPa, median TE (25^th–75^th percentile)	7.1 (5.3–10.3)	6.6 (4.5–12.2)	7.4 (5.5–10.4)	4.9 (4.3–7.5)
Corpechot et al 2012^*, no. (%) F0-1 (≤8.7 kPa) F2 (8.8–10.6 kPa) F3 (10.7–16.8 kPa) F4 (≥16.9 kPa)	360 (63.3) 82 (14.4) 58 (10.2) 69 (12.1)	10 (62.5) 2 (12.5) 2 (12.5) 2 (12.5)	321 (62.3) 73 (14.2) 55 (10.7) 66 (12.8)	29 (76.3) 7 (18.4) 1 (2.6) 1 (2.6)

All patients (N = 569)

Previously on UDCA (n = 16)

Currently on UDCA (n = 515)

Never on UDCA (n = 38)

Liver stiffness, kPa, median TE (25^th–75^th percentile)

7.1 (5.3–10.3)

6.6 (4.5–12.2)

7.4 (5.5–10.4)

4.9 (4.3–7.5)

Corpechot et al 2012^*, no. (%)

F0-1 (≤8.7 kPa)

F2 (8.8–10.6 kPa)

F3 (10.7–16.8 kPa)

F4 (≥16.9 kPa)

360 (63.3)

82 (14.4)

58 (10.2)

69 (12.1)

10 (62.5)

2 (12.5)

321 (62.3)

73 (14.2)

55 (10.7)

66 (12.8)

29 (76.3)

7 (18.4)

1 (2.6)

^* Liver stiffness measures (LSM) were assessed by transient elastography (TE): fibrosis stage F0-1 is associated with LSM of 8.7 kPa or, F2 with a LSM of 8.8 kPa to 10.6 kPa, F3 with a LSM of 10.7 kPa to 16.8 kPa, and F4 with a LSM of 16.9 kPa or more

UDCA = ursodeoxycholic acid; TE = transient elastography